GlassScriptPhysician profile
Amanda N Fredette
NPI 1083173421
$4,444.52
in general payments reported to CMS, 2019-2025
19 companies · $1,672 in 2025
The $1,672 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $287 · 2022: $393 · 2023: $1,117 · 2024: $976 · 2025: $1,672.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,543 · Education: $222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,543.19 |
| Education | $221.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $726.79 | 2022-2025 | |
| Amgen INC. | $656.22 | 2021-2025 | Otezla, Otezla |
| Janssen Biotech, INC. | $438.56 | 2021-2025 | Tremfya, Simponi, Simponi Aria |
| Leo Pharma INC. | $433.34 | 2022-2025 | Adbry, Anzupgo |
| Pfizer INC. | $334.60 | 2022-2025 | |
| Dermavant Sciences, INC. | $288.87 | 2022-2023 | Vtama |
| Regeneron Healthcare Solutions, INC. | $254.50 | 2022-2025 | Dupixent |
| Arcutis Biotherapeutics, INC. | $214.97 | 2024-2025 | Zoryve |
| Galderma Laboratories, L.P. | $188.80 | 2024-2025 | Nemluvio, Aklief |
| Genzyme Corporation | $169.56 | 2021-2024 | |
| Novartis Pharmaceuticals Corporation | $154.64 | 2025 | |
| Vyne Pharmaceuticals INC. | $139.31 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $133.14 | 2023 | Sotyktu |
| Incyte Corporation | $106.92 | 2021-2023 | Opzelura |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $79.10 | 2025 | Cabtreo |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $45.99 | 2022-2025 | Ebglyss, Taltz |
| Organon LLC | $45.01 | 2025 | Vtama |
| Botanix Sb INC | $19.44 | 2025 | Sofdra |
| Verrica Pharmaceuticals INC. | $14.76 | 2024 | Ycanth |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Fredette listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.